177
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Gelatin tannate reduces the proinflammatory effects of lipopolysaccharide in human intestinal epithelial cells

, , , &
Pages 61-67 | Published online: 08 May 2012

References

  • MacDermottRPAlterations of the mucosal immune system in inflammatory bowel diseaseJ Gastroenterol19963169079169027661
  • HuangYLiNLiboniKNeuJGlutamine decreases lipopolysaccharide- induced IL-production in Caco-2 cells through a non-NF-kappaB p50 mechanismCytokine2003223–4778312849706
  • EckmannLJungHCSchürer-MalyCPanjaAMorzycka-WroblewskaEKagnoffMFDifferential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8Gastroenterology19931056168916978253345
  • WalkerWARole of nutrients and bacterial colonization in the development of intestinal host defenseJ Pediatr Gastroenterol Nutr200030Suppl 2S2S710749395
  • ArdizzoneSBianchi PorroGBiologic therapy for inflammatory bowel diseaseDrugs200565162253228616266194
  • YoshidaTAmakuraYYoshimuraMStructural features and biological properties of ellagitannins in some plant families of the order myrtalesInt J Mol Sci20101117910620162003
  • YoshidaTHatanoTItoHHigh molecular weight plant polyphenols (tannins): Prospective functionsRecent Adv Phytochemistry200539163190
  • ZhangJLiLKimSHHagermanAELüJAnti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloylglucosePharm Res20092692066208019575286
  • FeldmanKSSahasrabudheKLawlorMDWilsonSLLangCHScheuchenzuberWJIn vitro and in vivo inhibition of LPS-stimulated tumor necrosis factor-alpha secretion by the gallotannin beta-D-pentagalloylglucoseBioorg Med Chem Lett200111141813181511459638
  • KangDGMoonMKChoiDHLeeJKKwonTOLeeHSVasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl- beta-D-glucose (PGG) via a nitric oxide-cGMP pathwayEur J Pharmacol20055241–311111916253226
  • AkiyamaHFujiiKYamasakiOOonoTIwatsukiKAntibacterial action of several tannins against Staphylococcus aureusJ Antimicrob Chemother200148448749111581226
  • ChungKTWongTYWeiCIHuangYWLinYTannins and human health: a reviewCrit Rev Food Sci Nutr19983864214649759559
  • KaurSGroverISSinghMKaurSAntimutagenicity of hydrolyzable tannins from Terminalia chebula in Salmonella typhimuriumMutat Res19984191–31691799804945
  • ShiTSUse of combined traditional Chinese and western medicine in the management of burnsPanminerva Med19832531972026669397
  • KhanNSAhmadAHadiSMAnti-oxidant, pro-oxidant properties of tannic acid and its binding to DNAChem Biol Interact2000125317718910731518
  • Sanchez-MorenoCLarrauriAJSaura-CalixtoFFree radical scavenging capacity and inhibition of lipid oxidation of wines, grape juices and related polyphenolic constituents – history, production and role in disease preventionFood Res Int1999326407412
  • ChungKTStevensSEJrLinWFWeiCIGrowth inhibition of selected food-borne bacteria by tannic acid, propyl gallate and related compoundsLett Appl Microbiol19931712932
  • ChungKTLuZChouMWMechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteriaFood Chem Toxicol19983612105310609862646
  • ScalbertAAntimicrobial properties of tanninsPhytochemistry1991301238753883
  • TaguriTTanakaTKounoIAntimicrobial activity of 10 different plant polyphenols against bacteria causing food-borne diseaseBiol Pharm Bull200427121965196915577214
  • LoebHVandenplasYWürschPGuesryPTannin-rich carob pod for the treatment of acute-onset diarrheaJ Pediatr Gastroenterol Nutr1989844804852723939
  • Esteban CarreteroJDurbán RegueraFLópez-Argüeta AlvarezSLópez MontesJA comparative analysis of response to ORS (oral rehydration solution) vs ORS + gelatin tannate in two cohorts of pediatric patients with acute diarrheaRev Esp Enferm Dig20091011414819335032
  • BrandtzaegPMolecular and cellular aspects of the secretory immunoglobulin systemAPMIS199510311197695886
  • GibsonPAndersonRMariadasonJWilsonAJProtective role of the epithelium of the small intestine and colonInflamm Bowel Dis199624279302
  • BaggioliniMChemokines in pathology and medicineJ Intern Med200125029110411489059
  • De DooyJJMahieuLMVan BeverHPThe role of inflammation in the development of chronic lung disease in neonatesEur J Pediatr2001160845746311548181
  • VignolaAMChanezPCampbellAMQuantification and localization of HLADR and intercellular adhesion molecule-1 (ICAM-1) molecules on bronchial epithelial cells of asthmatics using confocal microscopyClin Exp Immunol19949611041097908615
  • ElgavishAEffects of Escherichia coli and E. coli lipopolysaccharides on the function of human ureteral epithelial cells cultured in serum-free mediumInfect Immun1993618330433128101508
  • ChanRDGreensteinSMSablayLAnalysis of adhesion molecule expression by tubular epithelial cells using urine immunocytologyActa Cytol19953934354427762329
  • AlbeldaSMSmithCWWardPAAdhesion molecules and inflammatory injuryFASEB J1994885045128181668
  • SimmonsDLThe role of ICAM expression in immunity and diseaseCancer Surv1995241411557553659
  • KellyCPO’KeaneJCOrellanaJHuman colon cancer cells express ICAM-1 in vivo and support LFA-1 dependent lymphocyte adhesion in vitroAm J Physiol19922636 Pt 1G864G8671362041
  • HuangGTEckmannLSavidgeTCKagnoffMFInfection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesionJ Clin Invest19969825725838755670
  • MensaLMarcoFVilaJGascónJRuizJQuinolone resistance among Shigella spp. isolated from travellers returning from IndiaJ Clin Microbiol Infect2008143279281
  • LiSTGrossmanDCCummingsPLoperamide therapy for acute diarrhea in children: systematic review and meta-analysisPLoS Med200743e9817388664
  • BaumgartDCSandbornWJInflammatory bowel disease: clinical aspects and established and evolving therapiesLancet200736995731641165717499606
  • GhoshSPanaccioneRAnti-adhesion molecule therapy for inflammatory bowel diseaseTherap Adv Gastroenterol201034239358
  • BrynskovJFoeghPPedersenGTumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel diseaseGut2002511374312077089
  • PerrierCRutgeertsPCytokine blockade in inflammatory bowel diseasesImmunotherapy20113111341135222053885
  • MagroFPortelaFManagement of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapiesBioDrugs201024Suppl 131421175228